5D'Amato RJ,Loughnan MS,Flynn E,et al.Thalidomide is an in hibitor of angiogeresis[J].Proc Natl Acad Sci USA,1994,91(9):4082-4085.
6Mesa RA,Rajkumar SV,Hanson CA,et al.Evaluation and clinical correlation of microvessel density in myelofibrosis with myeloid metaplasia[J].Blood,1999,94(Suppl 1):115.
7Giovanni B, Michelle E, Letizia C, et al.Thalidomide in myelofibroslswith myeloid metaplasia.-a pooled-analysis of individual patient data from five studies. Leuk Lymphoma, 2002, ,I3 (12) : 2301-2307.
8Visani G, Mele A, Malagola M, et al. Sequential combination of thalidomideand erythropoietin determines transfusion independence an d disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents. Leukemia, 2003,17 (8) : 1669-1670.
